SCHEMBL26744995

SCHEMBL26744995

c1ccc2cc3sc(-c4nc5cc6cc7sc(-c8cc9cc%10ccccc%10cc9s8)nc7cc6cc5s4)cc3cc2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 11/20 0.39
▸ RAB9A P51151 9/20 0.39
▸ NPC1 O15118 8/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ SMN1; SMN2 Q16637 8/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ MAPT P10636 6/20 0.38
▸ HPGD P15428 4/20 0.38
▸ TP53 P04637 3/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ NPSR1 Q6W5P4 2/20 0.38
▸ PPARG P37231 1/20 0.38
▸ NCOA2 Q15596 1/20 0.38
▸ NCOA1 Q15788 1/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ NCOA3 Q9Y6Q9 1/20 0.38
▸ MEN1 O00255 3/20 0.37
▸ KMT2A Q03164 3/20 0.37
▸ PKM P14618 3/20 0.37
▸ GLA P06280 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26746758 0.88 APP (0.45) KDM4ERAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL26500587 0.81 APP (0.47) KDM4ERAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL26745039 0.81 KDM4E (0.37) KDM4ERAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL26744927 0.80 PIK3CA (0.47) KDM4ERAB9ANPC1SMN1; SMN2ALDH1A1
SCHEMBL26744918 0.80 NPC1 (0.45) KDM4ERAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL26500572 0.80 KDM4E (0.36) KDM4ERAB9ANPC1L3MBTL1ALDH1A1
SCHEMBL26744937 0.79 SMN1; SMN2 (0.46) KDM4ERAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL26745073 0.78 NQO2 (0.38) KDM4ERAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL26745077 0.78 CYP1B1 (0.38) KDM4ERAB9ANPC1L3MBTL1SMN1; SMN2
SCHEMBL26745036 0.78 APP (0.49) KDM4ERAB9ANPC1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230345826-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFILM CORPORATION (JP) 2023-10-26 — — US disclosed
US-20230345826-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFILM CORPORATION (JP) 2023-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230345826-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND TEAD1, CRY1, CPNE4 KDM4E 1242/4885RAB9A 2451/4885NPC1 2272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback